Registro:

Referencias:

• Dubrovsky, B.O. Steroids, neuroactive steroids and neurosteroids in psychopathology. Prog. Neuropsychopharmcol. Biol. Psychiatry, 2005, 29, 169-84; van Broekhoven, F., Verkes, R.J., Neurosteroids in depression: A review (2003) Psychopharmacology, 165, pp. 97-110
• Hamilton, N.M., Interaction of steroids with GABAA receptor (2002) Curr. Top. Med. Chem, 2, pp. 887-902
• Lambert, J.J., Belelli, D., Peden, D.R., Vardy, A.W., Peters, J.A., Neurosteroid modulation of GABAA receptors (2003) Prog. Neurobiol, 71, pp. 67-80
• Belelli, D., Lambert, J.J., Neurosteroids: Endogenous regulators of the GABAA receptor (2005) Nat. Rev. Neurosci, 6, pp. 565-575
• Akk, G., Covey, D.F., Evers, A.S., Steinbach, J.H., Zorumski, C.F., Mennerick, S., Mechanisms of neurosteroid interactions with GABAA receptors (2007) Pharmacol. Ther, 116, pp. 35-57
• Hosie, A.M., Wilkins, M.E., da Silva, H.M.A., Smart, T.G., Endogenous neurosteroids regulate GABAA receptors via two discrete transmembrane sites (2006) Nature, 444, pp. 486-489
• Mellon, S.H., Griffin, L.D., Neurosteroids: Biochemistry and clinical significance (2002) Trends Endocrinol. Metab, 19, pp. 35-43
• Maguire, J., Mody, I., Neurosteroid synthesis-mediated regulation of GABAA receptors: Relevance to the ovarian cycle and stress (2007) J. Neurosci, pp. 2155-2162
• Majewska, M.D., Harrison, N.L., Schwartz, R.D., Barker, J.L., Paul, S.M., Steroid hormone metabolites are barbiturate-like modulators of the GABAA receptor (1986) Science, 232, pp. 1004-1007
• Squires, R.F., Casida, J.F., Richardson, M., Saederup, E., 35S]-t- butylbicyclophosphorothionate binds with high affinity to brain specific sites coupled to a γ-aminobutyric-A and ion recognition sites (1983) Mol. Pharmacol, 23, pp. 326-336
• Liljequist, S., Tabakoff, B., Bicuculline-produced regional differences in the modulation of the 35S-TBPS binding by GABA, pentobarbital and diazepam in mouse cerebellum and cortex (1993) J. Pharmacol. Exp. Ther, 264, pp. 638-647
• Gee, K.W., Bolger, M.B., Brinton, R.E., Coirini, H., McEwen, B.S., Steroid modulation of the chloride ionophore in rat brain: Structure-activity requirements, regional dependence, and mechanism action (1988) J. Pharmacol. Exp. Ther, 246, pp. 803-812
• Im, W.B., Blakeman, D.P., Correlation between GABAA receptor-ligand induced changes in t-butylcyclophosphoro[35S]thionate binding and 36Cl-uptake in rat cerebrocortical membranes (1991) Mol. Pharmacol, 39, pp. 394-398
• Hawkinson, J.E., Kimbrough, C.L., Belelli, D., Lambert, J.J., Purdy, R.H., Lan, N.C., Correlation of neuroactive steroid modulation of [35S]t-butylbicyclophosphorothionate and [3H]flunitrazepam binding and γ-amominobutyric acidA receptor function (1994) Mol. Pharmacol, 46, pp. 977-985
• VanRijn, C.M., Dirksen, R., Willems-vanBree, E., Maksay, G., Diazepam biphasically modulates [3H]TBOB binding to the convulsant site of the GABAA receptor complex (1995) J. Recept. Sig. Transd. Res, 15, pp. 787-800
• Souli, C., Avlonitis, N., Calogeropoulou, T., Tsotinis, A., Maksay, G., Biró, T., Politi, A., Papadopoulos, M., Novel 17β-substituted conformationally constrained neurosteroids that modulate GABAA receptors (2005) J. Med. Chem, 48, pp. 5203-5214
• Harrison, N.L., Simmonds, M.A., Modulation of the GABA receptor complex by a steroid anaesthetic (1984) Brain. Res, 323 (287), p. 92
• Morrow, A.L., Suzdak, P.D., Paul, S.M., Steroid hormone metabolites potentiate GABA receptor-mediated chloride ion flux with nanomolar potency (1987) Eur. J. Pharmacol, 142, pp. 483-485
• Gyermek, L., Iriarte, J., Crabbe, P., Steroids CCCX. Structure-activity relationship of some steroidal hypnotic agents (1968) J. Med. Chem, 11, pp. 117-125
• Mennerick, S., He, Y., Jiang, X., Manion, B.D., Wang, M., Shute, A., Benz, A., Zorumski, C.F., Selective antagonism of 5α-reduced neurosteroid effects at GABAA receptors (2004) Mol. Pharmacol, 65, pp. 1191-1197
• Purdy, R.H., Morrow, A.L., Blinn, J.R., Paul, S.M., Synthesis, metabolism, and pharmacological activity of 3α-hydroxy steroids which potentiate GABA-receptor-mediated chloride ion uptake in rat cerebral cortical synaptoneurosomes (1990) J. Med. Chem, 33, pp. 1572-1581
• Sear, J.W., Steroids anesthetics: Old compounds, new drugs (1996) J. Clin. Anesth, 8, pp. 918-985
• Harrison, N.L., Majewska, M.D., Harrington, J.W., Baker, J.L., Structure-activity relationships for steroid interaction with the γ-aminobutyric acid (A) receptor complex (1987) J. Pharmacol. Exp. Ther, 241, pp. 343-353
• Turner, D.M., Ransom, R.W., Yang, J.S., Olsen, R.W., Steroid anesthetics and naturally occurring analogs modulate the γ-aminobutiric acid receptor complex at a site distinct from barbiturates (1989) J. Pharmacol. Exp. Ther, 248, pp. 960-966
• Belleli, D., Lan, N.C., Gee, K., Anticonvulsant steroids and the GABA/ benzodiazepine receptor-chloride ionophore complex (1990) Neurosci. Biobehav. Rev, 14, pp. 315-322
• Anderson, A., Boyd, A.C., Clark, J.K., Fielding, L., Gemmell, D.K., Hamilton, N.M., Maidment, M.S., Taylor, R., Conformationally constrained anesthetic steroids that modulate GABAA receptors (2000) J. Med. Chem, 43, pp. 4118-4125
• Jiang, X., Manion, B.D., Benz, A., Rath, N.P., Evers, A.S., Zorumski, C.F., Mennerick, S., Covey, D.F., Neurosteroid analogues.9. Conformationally constrained pregnanes: Structure-activity studies of 13,24-cyclo-18,21-dicorcholane analogues of the (3α,5β)-3- hydroxypregnan-20-one (2003) J. Med. Chem, 46, pp. 5334-5348
• Bolger, M.B., Wieland, S., Hawkinson, J.E., Xia, H., Upasani, R., Lan, N.C., In vitro and in vivo activity of 16,17-dehydroepipregnanolones: 17,20-bond torsional energy analysis and D-ring conformation (1996) Pharm. Res, 13, pp. 1488-1494
• Schering, A.G., D-Homo-20-keto-pregnanes (1977), British Patent appl.1494097 December; Covey, D.F., Han, M., Sampath Kumar, A., de la Cruz, M.A.M., Meadows, E.S., Hu, Y., Tonnies, A., Mennerick, S., Neurosteroid analogues. 8. Structure-activity studies of N-acylated 17a-aza-D homosteroid analogues of the anesthetic steroids (3α,5α)-and (3α, 5β)-3-hydroxypregnan-20-one (2000) J. Med. Chem, 43, pp. 3201-3204
• Hogenkamp, D.J., Hasan Tahir, S., Hawkinson, J.E., Upasani, R.B., Alauddin, M., Kimbrough, C., Acosta-Burruel, M., Bolger, M.B., Synthesis and in vitro activity of 3β-substituted-3α- hydroxypregnan-20-ones: Allosteric modulators of the GABAA receptor (1997) J. Med. Chem, 40, pp. 61-72
• Gasior, M., Carter, R.B., Goldberg, S.R., Witkin, J.M., Anticonvulsant and behavioral effects of neuroactive steroids alone and in conjuction with diazepam (1997) J. Pharmacol. Exp. Ther, 282, pp. 543-552
• Gasior, M., Carter, R.B., Witkin, J.M., Neuroactive steroids: Potential therapeutic use in neurological and psychiatric disorders (1999) TiPS, 20, pp. 107-112
• Upasani, R.B., Yang, K.C., Acosta-Burruel, M., Konkoy, C.S., McLellan, J.A., Woodward, R.M., Lan, N.C., Hawkinson, J.E., 3α-Hydroxy-3β-(phenylethynyl)-5β-pregnan-20-ones: Synthesis and pharmacological activity of neuroactive steroids with high affinity for GABAA receptors (1997) J. Med. Chem, 40, pp. 73-84
• Van Hemetrijck, J., Muller, P., Van Aken, H., White, P.F., Relative potency of eltanolone, propofol, and thiopental for induction of anesthesia (1994) Anesthesiology, 80, pp. 36-41
• Sear, J.W.E., 50 years on and still looking for steroid hypnotic agents (1998) Eur. J. Anaesthesiol, 15, pp. 12-132
• Sear, J.W., Steroidal anaesthetic agents (1998) Anaesthesiol. Pharmacol. Rev, 3, pp. 57-66
• Anderson, A., Boyd, A.C., Byford, A., Campbell, A.C., Gemmell, D.K., Hamilton, N.M., Hill, D.R., Sundaram, H., Anesthetic activity of novel watersoluble 2β-morpholinyl steroids and their modulatory effects at GABAA receptors (1997) J. Med. Chem, 40, pp. 1668-1681
• Hewett, C.L., Savage, D.S., Lewis, J.J., Sugrue, M.F., Anticonvulsant and interneuronal blocking activity in some synthetic amino steroids (1964) J. Pharm. Pharmacol, 16, pp. 765-767
• Slavíková, B., Kasal, A., Chodounská, H., Kristofíkova, Z., 3α-fluoroanalogues of allopregnanolone and their binding to GABAA receptors. Z (2002) Collect. Czech. Chem., Commun, 67, pp. 30-46
• Slavíková, B., Kasal, A., Uhlírová, L., Krsiak, M., Chodounská, H., Kohout, L., Suppressing aggressive behavior with analogs of allopregnanolone (epalon) (2001) Steroids, 66, pp. 99-105
• Matyás, L., Kasal, A., Riera, Z.B., Suñol, C.E., Effects of 3α-amino- 5α-pregnan-20-one-on GABAA receptor: Synthesis. Activity and cytotoxicity (2004) Collect. Czech. Chem. Commun, 69, pp. 1506-1509
• Han, M., Zorumski, C.F., Covey, D.F., Neurosteroid analogues. 4. The effect of methyl substitution at the C-5 and C-10 positions of neurosteroids on electrophysiological activity at GABAA receptors (1996) J. Med. Chem, 39, pp. 4218-4232
• Zeng, C., Manion, B.D., Benz, A., Evers, A.S., Zorumski, C.F., Mennerick, S., Covey, D.F., Neurosteroid analogues. 10. The effect of methyl group substitution at the C-6 and C-7 positions on the GABA modulatory and anesthetic actions of (3α,5α)-and (3α,5β)- 3-hydroxypregnan-20-one (2005) J. Med. Chem, 48, pp. 3051-3059
• Suñol, C., Garcia, D.A., Bujons, J., Kristofíkova, Z., Matyas, L., Babot, Z., Kasal, A., Activity of B-nor analogues of neurosteroids on the GABAA receptor in primary neuronal cultures (2006) J. Med. Chem, 49, pp. 3225-3234
• Dorfman, R.I., Fajkos, J., Joska, J., Biological activity of various steroids including B-norsteroids (1964) Steroids, 3, pp. 675-686
• Nicoletti, D., Ghini, A.A., Furtmüller, R., Sieghart, W., Dodd, R.H., Burton, G., Synthesis and GABAA receptor activity of 6-oxa-analogs of neurosteroids (2000) Steroids, 65, pp. 349-356
• Durán, F.J., Ghini, A.A., Coirini, H., Burton, G., Synthesis of 6-thia analogs of the natural neurosteroid allopregnanolone (2006) Tetrahedron, 62, pp. 4762-4768
• Veleiro, A.S., Rosenstein, R.E., Jaliffa, C.O., Grilli, M.L., Speroni, F., Burton, G., Synthesis and GABAA receptor activity of a 6,19-oxido analogue of pregnanolone (2003) Bioorg. Med. Chem. Lett, 13, pp. 343-346
• Alvarez, L.D., Veleiro, A.S., Baggio, R.F., Garland, M.T., Edelsztein, V.C., Coirini, H., Burton, G., Synthesis and GABAA receptor activity of oxygen-bridged neurosteroid analogs (2008) Bioorg. Med. Chem, 16, pp. 3831-3838
• Burden, P.M., Allan, R.D., Hambley, T., Johnston, G.A.R., The synthesis of 2-cyclohexylideneperhydro-4,7-methanoindenes. Nonsteroidal analogues of steroidal GABAA receptor modulators (1998) J. Chem. Soc. Perkin Trans. 1, pp. 3163-3169
• Covey, D.F., Hu, Y., Bouley, M.G., Holland, K.D., Rodgers-Neame, N.T., Isenberg, K.E., Zorumski, C.F., Modulation of GABAA receptor function by benz[e]indenes and phenanthrenes (1993) J. Med. Chem, 36, pp. 627-630
• Scaglione, J.B., Jastrzebska, I., Krishnan, K., Li, P., Akk, G., Manion, B.D., Benz, A., Covey, D.F., Neurosteroid analogues. 14. Alternative ring system scaffolds: GABA modulatory and anesthetic actions of cylopenta [b]phenanthrenes and cyclopenta [b]anthracenes (2008) J. Med. Chem, 51, pp. 1309-1318. , and references cited therein
• Hosie, A.M., Wilkins, M.E., Smart, T.G., Neurosteroid binding sites on GABAA receptor (2007) Pharmacol. Ther, 116, pp. 7-19
• Mokrab, Y., Bavro, V.N., Mizuguchi, K., Todorov, N.P., Martin, I.L., Dunn, S.M.J., Chan, S.L., Chau, P.-L., Exploring ligand recognition and ion flow in comparative models of the human GABA type A receptor (2007) J. Mol. Graph. Mod, 26, pp. 760-774
• Ernst, M., Bruckner, S., Boresch, S., Sieghart, W., Comparative models of GABAA receptor extracellular and transmembrane domains: Important insights in pharmacology and function (2005) Mol. Pharmacol, 68, pp. 1291-1300

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------